Ali Kibar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ali Kibar has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Sertaç Asa
İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye
6 shared publications - Kerim Sönmezoğlu
İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye
5 shared publications - Sait Sager
İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye
5 shared publications - Lebriz Uslu-Beşli
Department Nuclear Medicine, Cerrahpasa Medicine Faculty, Istanbul University - Cerrahpasa, Istanbul, Türkiye
4 shared publications Haluk Burcak Sayman
Department of Nuclear Medicine
3 shared publications- Haluk Burçak Sayman
Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey
3 shared publications
Latest Publications
- 11 November 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
A Case of Myoepithelioma Mimicking Metastasis on PSMA PET/CT
Myoepithelioma is a rare neoplasm that is usually benign and is most often described in adults. We describe an incidental focus of increased PSMA uptake in the region of the distal phalanx of the great toe in a patient undergoing PSMA PET/CT for initial staging of prostate cancer. While the intense tracer accumulation was initially suspicious for an atypical solitary metastasis, subsequent MRI revealed a well-circumscribed soft tissue lesion. The patient underwent surgical excision, and the diagnosis of myoepithelioma was confirmed. This case highlights that myoepithelioma may represent a rare pitfall in PSMA PET/CT interpretation.
- 11 November 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
A Case of Myoepithelioma Mimicking Metastasis on PSMA PET/CT
Myoepithelioma is a rare neoplasm that is usually benign and is most often described in adults. We describe an incidental focus of increased PSMA uptake in the region of the distal phalanx of the great toe in a patient undergoing PSMA PET/CT for initial staging of prostate cancer. While the intense tracer accumulation was initially suspicious for an atypical solitary metastasis, subsequent MRI revealed a well-circumscribed soft tissue lesion. The patient underwent surgical excision, and the diagnosis of myoepithelioma was confirmed. This case highlights that myoepithelioma may represent a rare pitfall in PSMA PET/CT interpretation.
- 26 July 2026
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 40 (12) , 1472-1482
Integrating functional and volumetric assessments in 90Y radioembolization: added value of [⁹⁹ᵐTc]Mebrofenin scintigraphy
- 26 July 2026
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 40 (12) , 1472-1482
Integrating functional and volumetric assessments in 90Y radioembolization: added value of [⁹⁹ᵐTc]Mebrofenin scintigraphy
- Open Access
- 26 November 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 35 (2) , 117-119
Complete Treatment Response of Isolated Lacrimal IgG4-Related Disease on 18F-FDG PET/CT Imaging
Complete Treatment Response of Isolated Lacrimal IgG4-Related Disease on 18F-FDG PET/CT Imaging - Molecular Imaging and Radionuclide Therapy
- 26 November 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 35 (2) , 117-119
Open AccessComplete Treatment Response of Isolated Lacrimal IgG4-Related Disease on 18F-FDG PET/CT Imaging
Complete Treatment Response of Isolated Lacrimal IgG4-Related Disease on 18F-FDG PET/CT Imaging - Molecular Imaging and Radionuclide Therapy
- 15 November 2025
- Published by Springer Nature in Nuclear Medicine and Molecular Imaging
- Vol. 60 (4) , 1-2
Rare Nodular Hepatosplenic Involvement in Multiple Myeloma: FDG PET/CT and MRI Correlation with Treatment Response
- 15 November 2025
- Published by Springer Nature in Nuclear Medicine and Molecular Imaging
- Vol. 60 (4) , 1-2
Rare Nodular Hepatosplenic Involvement in Multiple Myeloma: FDG PET/CT and MRI Correlation with Treatment Response
- 1 August 2025
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 46 (11) , 1078-1089
Head-to-head comparison of [18F] fluorodeoxyglucose PET/CT and [68Ga]Ga-prostate specific membrane antigen-11 PET/CT in radioactive iodine refractory differentiated thyroid cancer
Objectives: Radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC) is associated with challenges in both imaging and treatment due to resistance to I-131. The aim of this study is to compare the lesion detection rates of [18F] fluorodeoxyglucose (FDG) PET/computed tomography [CT] and [68Ga]Ga-prostate specific membrane antigen (PSMA)-11 PET/CT, and to investigate the theranostic potential of PSMA in RAIR-DTC. Methods: Thirty-eight RAIR-DTC patients followed between 2022 and 2024 underwent [18F]FDG PET/CT and [68Ga]Ga-PSMA-11 PET/CT. Lesions with uptake exceeding background activity were considered positive, while physiological uptake areas and benign-appearing foci were excluded. Lesion maximum standardized uptake value (SUVmax), tumor-to-background ratio (TBR), and detection rates were calculated and compared. Results: [18F]FDG PET/CT detected more lesions overall than [68Ga]Ga-PSMA-11 PET/CT (96.8 vs. 60.1%), particularly in the thyroid bed, lymph nodes, and lungs. However, both modalities identified the same number of bone lesions. While [18F]FDG PET/CT was superior in most patients, [68Ga]Ga-PSMA-11 PET/CT detected more lesions in a subset of patients and performed better in the pure classic papillary thyroid carcinoma subtype compared to other subtypes (71.7 vs. 50.3%). SUVmax and TBR values were higher on [18F]FDG PET/CT, yet in 14 patients (36.8%), [68Ga]Ga-PSMA-11 PET/CT identified lesions with SUVmax exceeding liver SUVmax, indicating potential eligibility for PSMA-based radionuclide therapy. Conclusion: Although [18F]FDG PET/CT demonstrated superior overall lesion detection, [68Ga]Ga-PSMA-11 PET/CT identified more lesions in a subset of patients. [68Ga]Ga-PSMA-11 PET/CT appears to be more beneficial in the pure classic subtype compared to other histological variants. Notably, [68Ga]Ga-PSMA-11 PET/CT demonstrated high uptake in a considerable number of patients and may provide theranostic value in RAIR-DTC patients with limited treatment options.
- 1 August 2025
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 46 (11) , 1078-1089
Head-to-head comparison of [18F] fluorodeoxyglucose PET/CT and [68Ga]Ga-prostate specific membrane antigen-11 PET/CT in radioactive iodine refractory differentiated thyroid cancer
Objectives: Radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC) is associated with challenges in both imaging and treatment due to resistance to I-131. The aim of this study is to compare the lesion detection rates of [18F] fluorodeoxyglucose (FDG) PET/computed tomography [CT] and [68Ga]Ga-prostate specific membrane antigen (PSMA)-11 PET/CT, and to investigate the theranostic potential of PSMA in RAIR-DTC. Methods: Thirty-eight RAIR-DTC patients followed between 2022 and 2024 underwent [18F]FDG PET/CT and [68Ga]Ga-PSMA-11 PET/CT. Lesions with uptake exceeding background activity were considered positive, while physiological uptake areas and benign-appearing foci were excluded. Lesion maximum standardized uptake value (SUVmax), tumor-to-background ratio (TBR), and detection rates were calculated and compared. Results: [18F]FDG PET/CT detected more lesions overall than [68Ga]Ga-PSMA-11 PET/CT (96.8 vs. 60.1%), particularly in the thyroid bed, lymph nodes, and lungs. However, both modalities identified the same number of bone lesions. While [18F]FDG PET/CT was superior in most patients, [68Ga]Ga-PSMA-11 PET/CT detected more lesions in a subset of patients and performed better in the pure classic papillary thyroid carcinoma subtype compared to other subtypes (71.7 vs. 50.3%). SUVmax and TBR values were higher on [18F]FDG PET/CT, yet in 14 patients (36.8%), [68Ga]Ga-PSMA-11 PET/CT identified lesions with SUVmax exceeding liver SUVmax, indicating potential eligibility for PSMA-based radionuclide therapy. Conclusion: Although [18F]FDG PET/CT demonstrated superior overall lesion detection, [68Ga]Ga-PSMA-11 PET/CT identified more lesions in a subset of patients. [68Ga]Ga-PSMA-11 PET/CT appears to be more beneficial in the pure classic subtype compared to other histological variants. Notably, [68Ga]Ga-PSMA-11 PET/CT demonstrated high uptake in a considerable number of patients and may provide theranostic value in RAIR-DTC patients with limited treatment options.
- Open Access
- 1 August 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 34 (3) , 242-245
Gluteal Muscle Metastasis of Papillary Thyroid Cancer with Increased Somatostatin Receptor Expression in 68Ga-DOTATATE PET/MRI
Gluteal Muscle Metastasis of Papillary Thyroid Cancer with Increased Somatostatin Receptor Expression in 68Ga-DOTATATE PET/MRI - Molecular Imaging and Radionuclide Therapy
- 1 August 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 34 (3) , 242-245
Open AccessGluteal Muscle Metastasis of Papillary Thyroid Cancer with Increased Somatostatin Receptor Expression in 68Ga-DOTATATE PET/MRI
Gluteal Muscle Metastasis of Papillary Thyroid Cancer with Increased Somatostatin Receptor Expression in 68Ga-DOTATATE PET/MRI - Molecular Imaging and Radionuclide Therapy
- 8 May 2025
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 51 (1) , e44-e45
FDG PET/CT Image of Extrarenal Wilms Tumor of Cervix
Wilms tumor is a rare type of cancer that mainly affects children. It’s the most common cancer of the kidneys in children. Although it is usually seen under the age of 3, it can also be diagnosed at older ages. Extrarenal Wilms tumor (ERWT) is very rare, comprising <1% of all Wilms tumor cases. It is most commonly seen in the retroperitoneum and pelvic region and has been reported in a limited number of patients in the literature. This report presents a patient with ERWT of the cervix who underwent FDG PET/CT imaging.
- 8 May 2025
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 51 (1) , e44-e45
FDG PET/CT Image of Extrarenal Wilms Tumor of Cervix
Wilms tumor is a rare type of cancer that mainly affects children. It’s the most common cancer of the kidneys in children. Although it is usually seen under the age of 3, it can also be diagnosed at older ages. Extrarenal Wilms tumor (ERWT) is very rare, comprising <1% of all Wilms tumor cases. It is most commonly seen in the retroperitoneum and pelvic region and has been reported in a limited number of patients in the literature. This report presents a patient with ERWT of the cervix who underwent FDG PET/CT imaging.
- 1 September 2024
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (9) , e476-e477
99mTc-PYP and 68Ga-FAPI PET/CT Images of Hereditary Transthyretin Amyloidosis With Cardiac Involvement
Amyloidosis is a protein misfolding disorder characterized by the extracellular deposition of insoluble amyloid fibrils, derived from abnormally folded proteins. These fibrils disrupt tissue structure and function, leading to organ dysfunction. The condition encompasses various subtypes, each associated with distinct precursor proteins and clinical manifestations. 99mTc-PYP scintigraphy is used widely and holds significant importance for diagnosis. 68Ga-FAPI is also a promising radiotracer for various diseases. To our knowledge, this is the first case of a patient with hereditary transthyretin amyloidosis with cardiac involvement, which FAPI PET showed diffuse increased myocardial uptake.
- 1 September 2024
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (9) , e476-e477
99mTc-PYP and 68Ga-FAPI PET/CT Images of Hereditary Transthyretin Amyloidosis With Cardiac Involvement
Amyloidosis is a protein misfolding disorder characterized by the extracellular deposition of insoluble amyloid fibrils, derived from abnormally folded proteins. These fibrils disrupt tissue structure and function, leading to organ dysfunction. The condition encompasses various subtypes, each associated with distinct precursor proteins and clinical manifestations. 99mTc-PYP scintigraphy is used widely and holds significant importance for diagnosis. 68Ga-FAPI is also a promising radiotracer for various diseases. To our knowledge, this is the first case of a patient with hereditary transthyretin amyloidosis with cardiac involvement, which FAPI PET showed diffuse increased myocardial uptake.
- Open Access
- 23 February 2024
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 33 (1) , 54-56
68Ga Prostate-specific Membrane Antigen Uptake in Metastatic Medullary Thyroid Carcinoma
We present the case of a 58-year-old man with advanced medullary thyroid carcinoma who had a treatment history with different types of modalities. In the follow-up, the patient had rising calcitonin and CEA levels. Metastatic lymph nodes, liver, and bone metastases with varying degrees of uptake were detected on 18F-fluorodeoxyglucose (FDG) and 68Ga-DOTATATE positron emission tomography/computed tomography (PET/CT). 68Ga prostate-specific membrane antigen (PSMA) PET/CT was performed to explore whether the patient might have a chance for PSMA-targeted radionuclide therapy, and increased PSMA expression was noted in most of the metastatic lesions, even some of which have higher PSMA uptake than 18F-FDG and 68Ga-DOTATATE.
- 23 February 2024
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 33 (1) , 54-56
Open Access68Ga Prostate-specific Membrane Antigen Uptake in Metastatic Medullary Thyroid Carcinoma
We present the case of a 58-year-old man with advanced medullary thyroid carcinoma who had a treatment history with different types of modalities. In the follow-up, the patient had rising calcitonin and CEA levels. Metastatic lymph nodes, liver, and bone metastases with varying degrees of uptake were detected on 18F-fluorodeoxyglucose (FDG) and 68Ga-DOTATATE positron emission tomography/computed tomography (PET/CT). 68Ga prostate-specific membrane antigen (PSMA) PET/CT was performed to explore whether the patient might have a chance for PSMA-targeted radionuclide therapy, and increased PSMA expression was noted in most of the metastatic lesions, even some of which have higher PSMA uptake than 18F-FDG and 68Ga-DOTATATE.
- 19 December 2023
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 51 (5) , 1467-1475
Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance
Purpose In our study, our aim was to investigate the role of [68 Ga]Ga-PSMA-11 PET /CT imaging in the diagnosis of clinically significant prostate cancer (csPCa) (ISUP GG 2 and higher) in patients initially diagnosed with ISUP GG 1 and 2 after prostate biopsy. Materials and methods We retrospectively reviewed 147 patient records in whom [68 Ga]Ga-PSMA-11 PET/CT imaging was performed preoperatively. All patients were initially diagnosed with ISUP GG 1 and 2 PCa by biopsy. Final pathology reports were obtained after radical prostatectomy. The [68 Ga]Ga-PSMA-11 PET/CT images were evaluated to determine the PRIMARY score. Patients’ mpMRI-PIRADS scores were also recorded when available and analyzed in correlation with the pathology results. Results For the 114 patients scored using PRIMARY, 19 out of 37 patients with scores of 1 and 2 (51%) were diagnosed with csPCa. Of the 77 patients with PRIMARY scores between 3 and 5, 64 (83%) had csPCa. Notably, every patient with a PRIMARY score of 5 had csPCa. PRIMARY scoring had a sensitivity of 77% and specificity of 58%, with a positive predictive value of 83%. A moderate correlation was observed between PRIMARY scores and ISUP GG (Rho = 0.54, p < 0.001). In contrast, the PIRADS score displayed a sensitivity and specificity of 86% and 25% respectively, with a positive predictive value of 68%. No substantial correlation was found between PIRADS and ISUP GG. Statistical analysis revealed a significant correlation between PRIMARY and ISUP GG (p < 0.001), but not between PIRADS and ISUP GG (p = 0.281). Comparatively, PRIMARY scoring was significantly more reliable than PIRADS scoring in identifying csPCa. Conclusion [68 Ga]Ga-PSMA-11 PET/CT imaging is promising for distinguishing high-risk prostate cancer patients from those apt for active surveillance, potentially aiding in the identification of csPCa.
- 19 December 2023
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 51 (5) , 1467-1475
Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance
Purpose In our study, our aim was to investigate the role of [68 Ga]Ga-PSMA-11 PET /CT imaging in the diagnosis of clinically significant prostate cancer (csPCa) (ISUP GG 2 and higher) in patients initially diagnosed with ISUP GG 1 and 2 after prostate biopsy. Materials and methods We retrospectively reviewed 147 patient records in whom [68 Ga]Ga-PSMA-11 PET/CT imaging was performed preoperatively. All patients were initially diagnosed with ISUP GG 1 and 2 PCa by biopsy. Final pathology reports were obtained after radical prostatectomy. The [68 Ga]Ga-PSMA-11 PET/CT images were evaluated to determine the PRIMARY score. Patients’ mpMRI-PIRADS scores were also recorded when available and analyzed in correlation with the pathology results. Results For the 114 patients scored using PRIMARY, 19 out of 37 patients with scores of 1 and 2 (51%) were diagnosed with csPCa. Of the 77 patients with PRIMARY scores between 3 and 5, 64 (83%) had csPCa. Notably, every patient with a PRIMARY score of 5 had csPCa. PRIMARY scoring had a sensitivity of 77% and specificity of 58%, with a positive predictive value of 83%. A moderate correlation was observed between PRIMARY scores and ISUP GG (Rho = 0.54, p < 0.001). In contrast, the PIRADS score displayed a sensitivity and specificity of 86% and 25% respectively, with a positive predictive value of 68%. No substantial correlation was found between PIRADS and ISUP GG. Statistical analysis revealed a significant correlation between PRIMARY and ISUP GG (p < 0.001), but not between PIRADS and ISUP GG (p = 0.281). Comparatively, PRIMARY scoring was significantly more reliable than PIRADS scoring in identifying csPCa. Conclusion [68 Ga]Ga-PSMA-11 PET/CT imaging is promising for distinguishing high-risk prostate cancer patients from those apt for active surveillance, potentially aiding in the identification of csPCa.